Endo International | Umlaufvermögen



Current Assets Veränderung Datum
AbbVie USD 25.58B 2.2B 2024-12
Amarin USD 573.06M 22.34M 2025-03
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Hikma Pharmaceutical USD 2.26B 22M 2024-12
Ligand Pharmaceuticals USD 309.32M 22.24M 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Takeda JPY 2.52T 233.1B 2025-03
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12
Zoetis USD 5.88B 109M 2025-03



Endo International Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.